COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
Language English Country Switzerland Media electronic-ecollection
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
35958845
PubMed Central
PMC9359622
DOI
10.3389/fpubh.2022.938067
Knihovny.cz E-resources
- Keywords
- COVID-19 vaccines, Poland, cross-sectional studies, decision making, healthcare professionals, vaccination hesitancy,
- MeSH
- COVID-19 * epidemiology prevention & control MeSH
- Humans MeSH
- Cross-Sectional Studies MeSH
- Surveys and Questionnaires MeSH
- SARS-CoV-2 MeSH
- Immunization, Secondary MeSH
- Students MeSH
- COVID-19 Vaccines MeSH
- Vaccines * MeSH
- Health Knowledge, Attitudes, Practice MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Poland MeSH
- Names of Substances
- COVID-19 Vaccines MeSH
- Vaccines * MeSH
Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.
Department of Anatomy Poznań University of Medical Sciences Poznań Poland
Department of Conservative Dentistry with Endodontics Medical University of Silesia Katowice Poland
Department of Diagnostics Poznań University of Medical Sciences Poznań Poland
Department of Microbiology and Virology Medical University of Silesia Sosnowiec Poland
Department of Pathology Medical University of Silesia Sosnowiec Poland
Department of Public Health Faculty of Medicine Masaryk University Brno Czechia
Doctoral School Poznań University of Medical Sciences Poznań Poland
See more in PubMed
Kadkhoda K. Herd immunity to COVID-19: alluring and elusive. Am J Clin Pathol. (2021) 155:471–2. 10.1093/ajcp/aqaa272 PubMed DOI PMC
Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. (2020) 52:737–41. 10.1016/j.immuni.2020.04.012 PubMed DOI PMC
Ritchie H, Edouard M, Lucas R-G, Cameron A, Charlie G, Esteban O-O, et al. . Coronavirus pandemic (COVID-19). Our World Data. (2022). Available online at: https://ourworldindata.org/coronavirus (accessed April 27, 2022).
Stay Up to Date With Your COVID-19 Vaccines. Centers Disease Control and Prevention; (2022). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html (accessed April 27, 2022).
Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. . Waning immune humoral response to BNT162b2 COVID-19 vaccine over 6 months. N Engl J Med. (2021) 385:e84. 10.1056/NEJMoa2114583 PubMed DOI PMC
Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, et al. . Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med. (2021) 385:e83. 10.1056/NEJMoa2114114 PubMed DOI PMC
Aleem A, Akbar Samad AB, Slenker AK. Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing. PubMed
Chenchula S, Karunakaran P, Sharma S, Chavan M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review. J Med Virol. (2022) 94:2969–76. 10.1002/jmv.27697 PubMed DOI PMC
Zdrowia M,. Komunikat nr 12 Ministra Zdrowia w sprawie szczepień przeciw COVID-19 dawka przypominajaca oraz dawka dodatkowa uzupełniajaca schemat podstawowy. Serwis Rzeczyposp Pol. (2021). Available online at: https://www.gov.pl/web/zdrowie/komunikat-nr-12-ministra-zdrowia-w-sprawie-szczepien-przeciw-covid-19-dawka-przypominajaca-oraz-dawka-dodatkowa-uzupelniajaca-schemat-podstawowy (accessed April 27, 2022).
The Chancellery of the Prime Minister. Prime Minister After Receiving a Booster Dose of the Vaccination: ”Getting vaccinated is the Best Gift We Can Give to Ourselves and Our Loved ones." Website Repub Pol (2021). Available online at: https://www.gov.pl/web/primeminister/prime-minister-after-receiving-a-booster-dose-of-the-vaccination-getting-vaccinated-is-the-best-gift-we-can-give-to-ourselves-and-our-loved-ones (accessed April 27, 2022).
Ministerstwo, Zdrowia,. Druga dawka przypominajaca dla osób 80+. Serwis Rzeczyposp Pol. Available online at: https://www.gov.pl/web/zdrowie/druga-dawka-przypominajaca-dla-osob-80 (accessed April 27, 2022).
Szczepienie przeciwko COVID-19. Raport szczepień przeciwko COVID-19. Serwis Rzeczyposp Pol. Available online at: https://www.gov.pl/web/szczepimysie/raport-szczepien-przeciwko-covid-19 (accessed April 27, 2022).
Rzymski P, Poniedziałek B, Fal A. Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines. (2021) 9:1286. 10.3390/vaccines9111286 PubMed DOI PMC
Babicki M, Mastalerz-Migas A. Attitudes of poles towards the COVID-19 vaccine booster dose: an online survey in Poland. Vaccines. (2022) 10:68. 10.3390/vaccines10010068 PubMed DOI PMC
MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, Gellin B, et al. . Vaccine hesitancy: definition, scope and determinants. Vaccine. (2015) 33:4161–4. 10.1016/j.vaccine.2015.04.036 PubMed DOI
Strategic Advisory Group of Experts on Immunization (SAGE). Report of the Sage Working Group on Vaccine Hesitancy. (2014). Available online at: https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf (accessed October 1, 2021).
Rosselli R, Martini M, Bragazzi NL. The old and the new: vaccine hesitancy in the era of the Web 2.0. Challenges and opportunities. J Prev Med Hyg. (2016) 57:E47. PubMed PMC
Riad A, Huang Y, Abdulqader H, Morgado M, Domnori S, Koščík M, et al. . Universal predictors of dental students' attitudes towards COVID-19 vaccination: machine learning-based approach. Vaccines. (2021) 9:1158. 10.3390/vaccines9101158 PubMed DOI PMC
Riad A, Abdulqader H, Morgado M, Domnori S, Koščík M, Mendes JJ, et al. . Global prevalence and drivers of dental students' COVID-19 vaccine hesitancy. Vaccines. (2021) 9:566. 10.3390/vaccines9060566 PubMed DOI PMC
Oberg EB, Frank E. Physicians' health practices strongly influence patient health practices. J R Coll Physicians Edinb. (2009) 39:290–1. 10.4997/JRCPE.2009.422 PubMed DOI PMC
Klugar M, Riad A, Mohanan L, Pokorná A. COVID-19 vaccine booster hesitancy (VBH) of healthcare workers in Czechia: national cross-sectional study. Vaccines. (2021) 9:1437. 10.3390/vaccines9121437 PubMed DOI PMC
Harvard Humanitarian Initiative,. Welcome to KoBoToolbox. KoBoToolbox Doc. (2022). Available online at: https://support.kobotoolbox.org/welcome.html (accessed January 4, 2022).
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. UroToday Int J. (2007) 335:806–8. 10.1136/bmj.39335.541782.AD PubMed DOI PMC
English Proficiency Index 2021. Education First (2021). Available online at: https://www.ef.com/wwen/epi/ (accessed January 12, 2022).
Centers for Disease Control Prevention (CDC). Population Survey or Descriptive Study. StatCalc | User Guide. Available online at: https://www.cdc.gov/epiinfo/user-guide/statcalc/samplesize.html (accessed December 1, 2021).
Attia S, Mausbach K, Klugar M, Howaldt H-P, Riad A. Prevalence and drivers of COVID-19 vaccine booster hesitancy (VBH) among German University Students and Employees. Front Public Heal. (2012) 10:846861. 10.3389/fpubh.2022.846861 PubMed DOI PMC
WMA . World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. (2013) 310:2191–4. 10.1001/jama.2013.281053 PubMed DOI
Proton Technologies AG,. General Data Protection Regulation (GDPR) Compliance Guidelines. Horiz 2020 - Proj REP-791727-1. (2020). Available online at: https://gdpr.eu/ (accessed May 1, 2020).
SPSS Inc,. IBM SPSS Statistics 28. (2021). Available online at: https://www.ibm.com/support/pages/ibm-spss-statistics-28-documentation (accessed March 14, 2021).
The jamovi project . jamovi (Version 1.6) [Computer Software]. (2021). Available online at: https://www.jamovi.org (accessed February 11, 2022).
Massimi A, Voglino G, Gualano MR, Chee Koh SW, Tan HM, Lee WH, et al. . COVID-19 vaccine booster hesitancy among healthcare workers: a retrospective observational study in Singapore. Vaccines. (2022) 10:464. 10.3390/vaccines10030464 PubMed DOI PMC
Batra K, Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, et al. . Factors associated with COVID-19 vaccine booster hesitancy: a retrospective cohort study, Fukushima vaccination community survey. Vaccines. (2022) 10:515. 10.3390/vaccines10040515 PubMed DOI PMC
Pal S, Shekhar R, Kottewar S, Upadhyay S, Singh M, Pathak D, et al. . COVID-19 vaccine hesitancy and attitude toward booster doses among US healthcare workers. Vaccines. (2021) 9:1358. 10.3390/vaccines9111358 PubMed DOI PMC
Folcarelli L, Del Giudice GM, Corea F, Angelillo IF. Intention to receive the COVID-19 vaccine booster dose in a university community in Italy. Vaccines. (2022) 10:146. 10.3390/vaccines10020146 PubMed DOI PMC
Lounis M, Bencherit D, Rais MA, Riad A. COVID-19 vaccine booster hesitancy (VBH) and its drivers in algeria: national cross-sectional survey-based study. Vaccines. (2022) 10:621. 10.3390/vaccines10040621 PubMed DOI PMC
Hu T, Li L, Lin C, Yang Z, Chow C, Lu Z, et al. . An analysis of the willingness to the COVID-19 vaccine booster shots among urban employees: evidence from a megacity H in Eastern China. Int J Environ Res Public Health. (2022) 19:2300. 10.3390/ijerph19042300 PubMed DOI PMC
Al-Qerem W, Al Bawab AQ, Hammad A, Ling J, Alasmari F. Willingness of the Jordanian population to receive a COVID-19 booster dose: a cross-sectional study. Vaccines. (2022) 10:410. 10.3390/vaccines10030410 PubMed DOI PMC
Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines. (2021) 9:1424. 10.3390/vaccines9121424 PubMed DOI PMC
Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, et al. . Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. Vaccine. (2021) 39:1148–56. 10.1016/j.vaccine.2020.12.083 PubMed DOI PMC
Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother. (2020) 16:2204–14. 10.1080/21645515.2020.1790279 PubMed DOI PMC
Shmueli L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health. (2021) 21:804. 10.1186/s12889-021-10816-7 PubMed DOI PMC
Eurostat . Majority of health jobs held by women. Products Eurostat News. (2021). Available online at: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20210308-1 (accessed May 2, 2022).
Organisation for Economic Co-operation and Development (OECD) . Young women are better educated than young men, but gender gaps in labour market outcomes persist. Closing Gender Gap. Available online at: https://www.oecd.org/gender/Closing the Gender Gap - Poland FINAL.pdf (accessed May 2, 2022).
Statista . Poland - average age of the population 1950-2050. Economic and Politics. Available online at: https://www.statista.com/statistics/375688/average-age-of-the-population-in-poland/ (accessed May 2, 2022).
Małgorzata Omyła-Rudzka,. Efekty uboczne szczepień przeciw COVID-19 - doświadczenia respondentów. Public Opinion Research Centre (2021). Available online at: https://www.cbos.pl/SPISKOM.POL/2021/K_081_21.PDF (accessed May 2, 2022).
Dziedzic A, Riad A, Attia S, Klugar M, Tanasiewicz M. Self-reported adverse events of COVID-19 vaccines in polish healthcare workers and medical students. Cross-sectional study and pooled analysis of CoVaST project results in Central Europe. J Clin Med. (2021) 10:5338. 10.3390/jcm10225338 PubMed DOI PMC
World Health Organization (WHO). WHO Coronavirus Dashboard With Vaccine Data. Available online at: https://covid19.who.int/region/euro/country/pl (accessed May 2, 2022).
Kuter BJ, Browne S, Momplaisir FM, Feemster KA, Shen AK, Green-McKenzie J, et al. . Perspectives on the receipt of a COVID-19 vaccine: a survey of employees in two large hospitals in Philadelphia. Vaccine. (2021) 39:1693–700. 10.1016/j.vaccine.2021.02.029 PubMed DOI PMC
Rabi R, Maraqa B, Nazzal Z, Zink T. Factors affecting nurses' intention to accept the COVID-19 vaccine: a cross-sectional study. Public Health Nurs. (2021) 38:781–8. 10.1111/phn.12907 PubMed DOI PMC
Szmyd B, Karuga FF, Bartoszek A, Staniecka K, Siwecka N, Bartoszek A, et al. . Attitude and behaviors towards SARS-CoV-2 vaccination among healthcare workers: a cross-sectional study from Poland. Vaccines. (2021) 9:218. 10.3390/vaccines9030218 PubMed DOI PMC
Riad A, Schünemann H, Attia S, Peričić TP, Žuljević MF, Jürisson M, et al. . COVID-19 vaccines safety tracking (CoVaST): protocol of a multi-center prospective cohort study for active surveillance of COVID-19 vaccines' side effects. Int J Environ Res Public Heal. (2021) 18:7859. 10.3390/ijerph18157859 PubMed DOI PMC
Lounis M, Rais MA, Bencherit D, Aouissi HA, Oudjedi A, Klugarová J, et al. . Side effects of COVID-19 inactivated virus versus adenoviral vector vaccines: experience of Algerian healthcare workers. Front Public Heal. (2022) 10:896343. 10.3389/fpubh.2022.896343 PubMed DOI PMC
Riad A, Hocková B, Kantorová L, Slávik R, Spurná L, Stebel A, et al. . Side effects of mRNA-based COVID-19 vaccine: nationwide phase IV study among healthcare workers in Slovakia. Pharmaceuticals. (2021) 14:873. 10.3390/ph14090873 PubMed DOI PMC
Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt H-P, et al. . Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German Healthcare Workers. Biology. (2021) 10:752. 10.3390/biology10080752 PubMed DOI PMC
Riad A, Sagiroglu D, Üstün B, Pokorná A, Klugarová J, Attia S, Klugar M. Prevalence and risk factors of CoronaVac side effects: an independent cross-sectional study among healthcare workers in Turkey. J Clin Med. (2021) 10:2629. 10.3390/jcm10122629 PubMed DOI PMC
Youssef D, Abou-Abbas L, Berry A, Youssef J, Hassan H. Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model. PLoS ONE. (2022) 17:e0264128. 10.1371/journal.pone.0264128 PubMed DOI PMC
Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, et al. . Measuring vaccine hesitancy: the development of a survey tool. Vaccine. (2015) 33:4165–75. 10.1016/j.vaccine.2015.04.037 PubMed DOI
Bar-On Bar-On YM. Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, et al. . Protection of BNT162b2 vaccine booster against COVID-19 in Israel. N Engl J Med. (2021) 385:1393–400. 10.1056/NEJMoa2114255 PubMed DOI PMC
Qin C, Wang R, Tao L, Liu M, Liu J. Association between risk perception and acceptance for a booster dose of COVID-19 vaccine to children among child caregivers in China. Front Public Heal. (2022) 10:514. 10.3389/fpubh.2022.834572 PubMed DOI PMC